Mechanism and Antiviral Therapy in Preventing Mother-to-Child Transmission During Pregnancy with Hepatitis B Virus Infection

被引:1
|
作者
Zhao, Mengyu [1 ,2 ]
Zou, Huaibin [1 ,2 ]
Chen, Yu [1 ,2 ]
Duan, Zhongping [1 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Difficult & Complicated Liver Dis & Artificial Li, Beijing, Peoples R China
[2] Beijing Municipal Key Lab Liver Failure & Artific, Beijing, Peoples R China
关键词
Antiviral Therapy; Hepatitis B Virus (HBV); Mother-to-Child Transmission (MTCT); Pregnancy; TENOFOVIR DISOPROXIL FUMARATE; CLINICAL-PRACTICE GUIDELINES; INFANT TRANSMISSION; SURFACE-ANTIGEN; INTRAUTERINE INFECTION; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; TELBIVUDINE TREATMENT; VACCINATION PROGRAM; HBV TRANSMISSION;
D O I
10.5812/hepatmon.81903
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Context: Mother-to-child transmission (MTCT) is one of the main transmission routes of chronic hepatitis B virus (HBV) infection. The successful rate of preventing MTCT has increased to over 90% after the administration of passive-active immunoprophylaxis (vaccine and hepatitis B immunoglobulin (HBIG)) on infants born to hepatitis B surface antigen (HBsAg)-positive mothers. However, 5%-10% of the infants had chronic HBV infection who were born to mothers with high HBV DNA levels. Therefore, the current domestic and international guidelines recommended that antiviral therapy in late pregnancy was to further decrease the MTCT rate. This study aimed at reviewing the mechanisms of MTCT and controversial issues in antiviral therapy for pregnant women with high viral load in order to provide clinicians with some strategies for preventing MTCT of HBV. Evidence Acquisition: Relevant English published papers were searched using online databases, including PubMed and EMBASE from January 2000 to January 2019. We summarized the findings of 61 relevant studies in this review. Results: The mechanism of MTCT is still unclear and further studies are needed. Antiviral therapy for pregnant women with high viral load can reduce the rate of MTCT and provide the appropriate safety for mothers and infants. Conclusions: The mechanisms underlying MTCT of HBV is still unknown and more investigations are required. The efficacy and safety of taking tenofovir disoproxil fumarate (TDF) orally in pregnant women with high viral load in the second or third trimester of pregnancy to block MTCT of HBV have been proved. The withdrawal of antiviral therapy during pregnancy due to MTCT should not exceed 3 months after delivery at the latest. Most pregnant women tend to suffer from increased alanine aminotransferase (ALT) after discontinuing antiviral drugs during pregnancy. Accordingly, close ALT levels monitoring after drug discontinuation is essential.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Hepatitis B virus infection: Prevention of mother-to-child transmission and exacerbation during pregnancy
    Sasagawa, Yuki
    Yamada, Hideto
    Morizane, Mayumi
    Deguchi, Masashi
    Shirakawa, Tokuro
    Morioka, Ichiro
    Tanimura, Kenji
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (08) : 621 - 625
  • [2] Prevention of Mother-To-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy
    Harlfinger, Julia
    Nussbaumer-Streit, Barbara
    Gartlehner, Gerald
    [J]. GESUNDHEITSWESEN, 2023, 85 (04) : 266 - 269
  • [3] Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus
    Eke, Ahizechukwu C.
    Eleje, George U.
    Eke, Uzoamaka A.
    Xia, Yun
    Liu, Jiao
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (02):
  • [4] Hepatitis C virus infection in pregnancy and the risk of mother-to-child transmission
    Polywka, S
    Feucht, H
    Zollner, B
    Laufs, R
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (02) : 121 - 124
  • [5] Hepatitis C virus infection in pregnancy and the risk of mother-to-child transmission
    S. Polywka
    H. Feucht
    B. Zöllner
    R. Laufs
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 1997, 16 : 121 - 124
  • [6] Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus (HBV)
    Eke, Ahizechukwu
    Yun, Xia
    Eke, Uzoamaka
    Eleje, George
    Jiao, Liu
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : S226 - S226
  • [7] Intrauterine Infection and Mother-to-Child Transmission of Hepatitis B Virus: Route and Molecular Mechanism
    Zhao, Xianlei
    Bai, Xiaoxia
    Xi, Yongmei
    [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 1743 - 1751
  • [8] Mother-to-child transmission of hepatitis C virus infection
    Newell, ML
    Pembrey, L
    [J]. DRUGS OF TODAY, 2002, 38 (05) : 321 - 337
  • [9] Prophylactic antiviral therapy for the prevention of mother-to-child transmission of hepatitis B virus can be stopped at delivery
    Zeng, Q. -L.
    Xu, G. -H.
    Wang, B.
    Li, Z. -Q.
    Yu, Z. -J.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S502 - S503
  • [10] Prophylactic antiviral therapy for the prevention of mother-to-child transmission of hepatitis B virus can be stopped at delivery
    Zeng, Q-L
    Xu, G-H
    Wang, B.
    Li, Z-Q
    Yu, Z-J
    [J]. JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 612 - 613